Last reviewed · How we verify

NCT04980287

Mesogastrium Metastasis in Colon Cancer

Recruiting now Last updated 10 April 2025
What this trial tests

trial in Colon Cancer in 50 participants. Currently enrolling.

Timeline
12 January 2021
Primary endpoint
19 July 2023
19 July 2026

Quick facts

Lead sponsorJichao Qin
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date12 January 2021
Primary completion19 July 2023
Estimated completion19 July 2026
Sites1 location across China

Conditions studied

Sponsor

Jichao Qin

Who can join

Adults 18 to 75, any sex, with Colon Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Colon Cancer

Currently open trials in the same condition.

Other Jichao Qin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04980287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing